Pharma firm opens $136m UAE planton Sep 10, 2012
Gulf Pharmaceutical Industries, Julphar, has opened its new $136m (AED: 500m) plant in Ras Al Khaimah which will be used for making and distributing insulin.
It will be capablee of producing 1,500kg of insulin a year - or around 45m vials. Capacity will be scaled up based on demand, the company said.
Julphar first began producing insulin eight years ago from crystals imported from Europe, but now produces the crystals in-house.
The company said that the market for insulin is likely to increase over the next few years.
"Some 20 per cent of the Gulf's population now has diabetes with the number likely to double by 2030 if action is not taken to contain the disease," it said.
- Arada to float Nasma Residences tender in May 2017
- In Pictures: What will Nasma Residences look like?
- Rotana, GGH ink deal for new 250-key hotel in Oman
- Swiss-Belhotel to open hotels in Egypt, Bahrain
- GCC imposes anti-dumping measures on Chinese pipes
- Dubai: UAE's first solar-powered gas station opens
- Video: Warner Bros Abu Dhabi 15 month time lapse
- 15 hotels worth $10bn to open in Bahrain by 2020
- Kone wins eight new orders for projects in Saudi
- Abu Dhabi: Indoor skydiving venue 50% complete